المؤلفون: Garrote i Ordeig, Marta

المساهمون: University/Department: Universitat de Barcelona. Facultat de Medicina i Ciències de la Salut

Thesis Advisors: Alvarez Larrán, Alberto

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Trombosi, Trombosis, Thrombosis, Malalties cardiovasculars, Enfermedades cardiovasculares, Cardiovascular diseases, Hematologia, Hematología, Hematology, Trastorns mieloproliferatius, Síndromes mieloproliferativos, Myeloproliferative disorders, Genòmica, Genómica, Genomics, Ciències de la Salut

Time: 616.1

وصف الملف: application/pdf

URL الوصول: http://hdl.handle.net/10803/692217

المؤلفون: Maher, Michael

المساهمون: University/Department: Universitat de Barcelona. Facultat de Biologia

Thesis Advisors: Buschbeck, Marcus, Villarroya Gombau, Francesc

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Àcids grassos, Ácidos grasos, Fatty acids, Metabolisme, Metabolismo, Metabolism, Epigenètica, Epigenética, Epigenetics, Leucèmia mieloide, Leucemia mieloide, Myeloid leukemia, Trastorns mieloproliferatius, Síndromes mieloproliferativos, Myeloproliferative disorders, Ciències Experimentals i Matemàtiques

وصف الملف: application/pdf

URL الوصول: http://hdl.handle.net/10803/673704

المصدر: Phase I/II Trial of Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Kouroukli O, Symeonidis A, Foukas P, Maragkou MK, Kourea EP. Bone Marrow Immune Microenvironment in Myelodysplastic Syndromes. Cancers (Basel). 2022 Nov 17;14(22):5656. doi: 10.3390/cancers14225656.

المصدر: A Randomized Phase II Study Comparing Cytarabine + Daunorubicin (7 + 3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin + Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome + Venetoclax in Patients Aged 59 or Younger Who Are Considered High-Risk (Adverse) Acute Myeloid Leukemia As Determined by MYELOMATCH; A MYELOMATCH Clinical Trial

Other URLs: https://grants.nih.gov/policy/sharing.htm

المصدر: A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

المصدر: Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Therapy

المؤلفون: Atrium Health Levine Cancer Institute, Brookdale University Hospital Medical Center

المصدر: Evaluation of the Pathobiology of CALR-mutated MPN Cells

المساهمون: Sarah Wall, Principal Investigator

المصدر: Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant Candidates to Improve Survival (OTIS)

المؤلفون: National Cord Blood Network

المصدر: Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics

المصدر: Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

المؤلفون: Rigel Pharmaceuticals

المصدر: A Phase 2 Study Evaluating Olutasidenib in Combination with Hypomethylating Agents in Patients with IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm

المصدر: A Phase 1b/2, Open-Label, Dose Finding, and Expansion Study of the Bcl-2 Inhibitor BGB-11417 in Patients With Myeloid Malignancies

المصدر: A Phase 3b, Open-label, Single-arm, Rollover Study to Evaluate Long-term Safety in Subjects Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Other URLs: https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosure-commitment.html

المؤلفون: National Institutes of Health (NIH), National Cancer Institute (NCI)

المساهمون: Marc Loriaux, Associate Professor

المصدر: Pathogenesis of Acute Leukemia, Lymphoproliferative Disorders, and Myeloproliferative Disorders

المؤلفون: AbbVie

المساهمون: Jacqueline Garcia, MD, Principal Investigator

المصدر: A Phase 1 Study of Triplet Therapy with Navitoclax, Venetoclax, and Decitabine for High-risk Myeloid Malignancies

المصدر: A Phase 2 Study of LY2784544 in Patients With Myeloproliferative Neoplasms

المساهمون: Razan Mohty, MD, Assistant Professor

المصدر: Phase II Clinical Trial of 2 Step ATG Combined with Tacrolimus and Mini Methotrexate for Prevention of Acute GVHD Post Reduced Intensity Allogeneic Stem Cell Transplant

المؤلفون: National Cancer Institute (NCI)

المصدر: Personalized NK Cell Therapy in CBT

المؤلفون: The Leukemia and Lymphoma Society

المساهمون: Frank Penedo, Professor

المصدر: The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A Multisite, Longitudinal Trial

المؤلفون: BeiGene

المصدر: A Phase 1 Open-Label, Multi-Center, Safety and Efficacy Study of PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With Relapsed/Refractory Hematologic Malignancies